Summit Therapeutics (SMMT) Depreciation and Depletion (2016 - 2025)
Historic Depreciation and Depletion for Summit Therapeutics (SMMT) over the last 10 years, with Q3 2025 value amounting to $42000.0.
- Summit Therapeutics' Depreciation and Depletion rose 11000.0% to $42000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $126000.0, marking a year-over-year increase of 2989.69%. This contributed to the annual value of $89000.0 for FY2024, which is 5505.05% down from last year.
- Latest data reveals that Summit Therapeutics reported Depreciation and Depletion of $42000.0 as of Q3 2025, which was up 11000.0% from $37000.0 recorded in Q2 2025.
- Over the past 5 years, Summit Therapeutics' Depreciation and Depletion peaked at $99000.0 during Q2 2022, and registered a low of $20000.0 during Q2 2024.
- Over the past 5 years, Summit Therapeutics' median Depreciation and Depletion value was $46000.0 (recorded in 2023), while the average stood at $56315.8.
- In the last 5 years, Summit Therapeutics' Depreciation and Depletion skyrocketed by 12571.43% in 2021 and then crashed by 7000.0% in 2024.
- Quarter analysis of 5 years shows Summit Therapeutics' Depreciation and Depletion stood at $79000.0 in 2021, then increased by 11.39% to $88000.0 in 2022, then plummeted by 65.91% to $30000.0 in 2023, then decreased by 26.67% to $22000.0 in 2024, then soared by 90.91% to $42000.0 in 2025.
- Its last three reported values are $42000.0 in Q3 2025, $37000.0 for Q2 2025, and $25000.0 during Q1 2025.